Updates regarding nuclear medicine in guidelines for differentiated thyroid carcinoma management
10.3760/cma.j.issn.2095-2848.2018.03.006
- VernacularTitle:有关分化型甲状腺癌核医学相关诊治的指南更新
- Author:
Yansong LIN
1
Author Information
1. 100730,中国医学科学院、北京协和医学院北京协和医院核医学科
- Keywords:
Thyroid neoplasms;
Nuclear medicine;
Practice guidelines
- From:
Chinese Journal of Nuclear Medicine and Molecular Imaging
2018;38(3):172-177
- CountryChina
- Language:Chinese
-
Abstract:
With the increasing of incidence,differentiated thyroid carcinoma (DTC) has become a global concern.Over the recent decades,the guidelines for the management of DTC has been kept updating along with the development of molecular biology and improvement of diagnosis and treatment approaches.Here we focus on the updates regarding nuclear medicine management of DTC in American Thyroid Association (ATA) and National Cancer Comprehensive Network (NCCN) guidelines.A brief interpretation is related from the roles of following perspectives with regards to the evaluation before radioactive iodine therapy and during follow-up,including the value of recurrence risk stratification,thyroglobulin (Tg),molecular pathology,nuclear medicine imaging and ongoing evaluation system.
